Position in SCYX
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$1,113,786
-$243,200 QoQ
Shares Held
1,762,322
0.0% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.809009931215748.ToString("F0")%
None 87.19099006878425.ToString("F0")%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $16,658,868,137 across 58 Drug Manufacturers - Specialty & Generic names. SCYX ranks #48 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
47,780,974 | $6,011,802,146 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,176,016 | $2,034,763,795 | |
| 3 | VTRS |
Viatris Inc
|
138,179,864 | $1,720,339,304 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,700,301 | $1,375,793,688 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
48,059,731 | $1,087,591,711 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
20,925,666 | $679,456,373 | |
| 7 | ALKS |
Alkermes plc.
|
18,007,364 | $503,846,043 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
6,699,381 | $445,843,803 |
All Filings in SCYX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,113,786 | 1,762,322 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,356,986 | 1,762,322 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,118,286 | 1,656,722 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,577,198 | 1,656,722 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,010,489 | 1,661,562 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,513,580 | 1,686,967 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,375,340 | 1,687,670 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,480,874 | 1,687,670 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,475,492 | 1,558,517 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $3,393,624 | 1,488,432 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $4,327,136 | 1,466,826 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,186,761 | 1,395,587 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $2,063,257 | 1,322,601 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,172,735 | 1,321,973 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,927,217 | 1,036,139 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,833,578 | 980,455 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,000,318 | 983,659 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,632,226 | 874,005 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,424,108 | 872,841 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,877,492 | 866,183 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,977,211 | 650,616 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,252,646 | 284,047 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||